Clinical Trials Directory

Trials / Completed

CompletedNCT01612403

Study the Effect of Oral Zinc Supplementation on High Molecular Weight Zinc Binding Protein in Semen

Status
Completed
Phase
Study type
Observational
Enrollment
37 (actual)
Sponsor
mahmoud hussein hadwan · Academic / Other
Sex
Male
Age
27 Years – 35 Years
Healthy volunteers
Not accepted

Summary

There are several causes leading to male infertility, like oxidative stress, and nutritional deficiency of trace elements like zinc. Zinc in human seminal plasma was divided into three types of ligands which are high (HMW), intermediate (IMW), and low molecular weight ligands (LMW). The present study was conducted to study the effect of Zn supplementation on the quantitative and qualitative characteristics of semen along with Zinc Binding Protein levels in semen of patients with asthenozoospmia.

Detailed description

Elevation of ROS levels lead to an increase the oxidation of HMW-Zn binding proteins in seminal plasma of asthenozoospermic subjects. Zinc supplementation restores HMW-Zn% in seminal plasma of asthenozoospermic subjects to normal value. LMW-Zn% is elevated in seminal plasma of asthenozoospermic patients. It may be because increment the levels of semenogelin in seminal plasma of asthenozoospermic subjects. Zinc supplementation elevates LMW-Zn% in seminal plasma of asthenozoospermic subjects to more than normal value, this may be because of its enhancement of the synthesis of metallothioneins (Low molecular weight zinc binding protein).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTzinc sulfateevery participant took two capsules of zinc sulfate per day for three months (each one 220mg)

Timeline

Start date
2011-07-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2012-06-05
Last updated
2012-06-06

Locations

2 sites across 1 country: Iraq

Source: ClinicalTrials.gov record NCT01612403. Inclusion in this directory is not an endorsement.